Guanylate Cyclase
GC (guanylyl cyclaese) converts GTP into cGMP and pyrophosphate. sGC (soluble GC) is a nitric oxide receptor and pGC (transmembrance GC) is a natriiuritic peptide receptor. Its major functions include cell hyperplasia,hypertrophy, cell differentiation and tumor progression etc.
Products Related to Guanylate Cyclase (29)
- GC11426BAY 41-8543CAS: 256498-66-5Purity: >99.50%
heme-dependent stimulator of soluble guanylate cyclase (sGC)
- GC19459Cinaciguat hydrochlorideCAS: 646995-35-9Purity: >99.50%
Cinaciguat hydrochloride is a potent soluble guanylate cyclase (GC) activator with EC50 of 15 nM in platelets.
- GC30016LinaclotideCAS: 851199-59-2Purity: >98.00%
A peptide agonist of the guanylate cyclase C receptor
- GC30051Methylene Blue (Basic Blue 9)CAS: 61-73-4Purity: >99.00%
Methylene blue (Basic Blue 9) is a guanylyl cyclase (sGC), monoamine oxidase A (MAO-A) and NO synthase (NOS) inhibitor.
- GC32472Vericiguat (BAY1021189)CAS: 1350653-20-1Purity: >98.00%
Vericiguat (BAY1021189) is an oral soluble guanylate cyclase (sGC) stimulant and an inhibitor of breast cancer resistance protein (IC 50 = 20µM) as well as OATP1B1 and 1B3 (approximate IC 50 of 16 and 30µM, respectively).
- GC32493Nelociguat (BAY60-4552)CAS: 625115-52-8Purity: >99.50%
Nelociguat (BAY60-4552) (BAY60-4552) is a nitric oxide sensitive soluble guanylate cyclase stimulator.
- GC33898Plecanatide acetateCAS: 1075732-84-1Purity: >99.00%
Plecanatide acetate, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist.
- GC34045(4-Acetamidocyclohexyl) nitrate (BM121307)CAS: 137213-91-3Purity: >98%
(4-Acetamidocyclohexyl) nitrate (BM121307) (BM121307) is a guanylate cyclase activator.
- GC36801OlinciguatCAS: 1628732-62-6Purity: >98.00%
Olinciguat (IW-1701) is an oral guanylate cyclase (sGC) stimulator with concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole cell assay.
- GC61604Guanylin(human) TFAPurity: >97.00%
Guanylin(human) TFA, a 15-amino acid peptide, is an endogenous intestinal guanylate cyclase activator.
- GC65051BAY 60-2770CAS: 1027642-43-8Purity: >98%
BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator.
- GC65182ZagociguatCAS: 2201048-82-8Purity: >99.00%
Zagociguat is the stimulator of soluble guanylate cyclase.
- GC65192RuncaciguatCAS: 1402936-61-1Purity: >99.00%
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10192 | BAY 41-2272 | 256376-24-6 | >99.50% | |
Activator of soluble guanylyl cyclase (sGC) | ||||
| GC10962 | Cinaciguat | 329773-35-5 | >99.00% | |
An activator of sGC | ||||
| GC11361 | Ataciguat | 254877-67-3 | >98.00% | |
Ataciguat is a nitric oxide-independent soluble guanylate cyclase (sGC) activator. | ||||
| GC11426 | BAY 41-8543 | 256498-66-5 | >99.50% | |
heme-dependent stimulator of soluble guanylate cyclase (sGC) | ||||
| GC12887 | Riociguat | 625115-55-1 | >99.50% | |
A stimulator of soluble guanylate cyclase | ||||
| GC13857 | LY83583 | 91300-60-6 | >99.00% | |
LY83583 is a membrane-permeable soluble guanylate cyclase (sGC) inhibitor. | ||||
| GC16406 | YC 1 | 170632-47-0 | >99.00% | |
Lificiguat (YC-1) is a no-dependent soluble guanylyl cyclase(sGC) activator and a Hypoxia-inducible faction-1alpha (HIF-1alpha) inhibitor. | ||||
| GC16975 | NS 2028 | 204326-43-2 | >99.50% | |
soluble guanylyl cyclase (sGC) inhibitor | ||||
| GC19459 | Cinaciguat hydrochloride | 646995-35-9 | >99.50% | |
Cinaciguat hydrochloride is a potent soluble guanylate cyclase (GC) activator with EC50 of 15 nM in platelets. | ||||
| GC30016 | Linaclotide | 851199-59-2 | >98.00% | |
A peptide agonist of the guanylate cyclase C receptor | ||||
| GC30051 | Methylene Blue (Basic Blue 9) | 61-73-4 | >99.00% | |
Methylene blue (Basic Blue 9) is a guanylyl cyclase (sGC), monoamine oxidase A (MAO-A) and NO synthase (NOS) inhibitor. | ||||
| GC32472 | Vericiguat (BAY1021189) | 1350653-20-1 | >98.00% | |
Vericiguat (BAY1021189) is an oral soluble guanylate cyclase (sGC) stimulant and an inhibitor of breast cancer resistance protein (IC 50 = 20µM) as well as OATP1B1 and 1B3 (approximate IC 50 of 16 and 30µM, respectively). | ||||
| GC32493 | Nelociguat (BAY60-4552) | 625115-52-8 | >99.50% | |
Nelociguat (BAY60-4552) (BAY60-4552) is a nitric oxide sensitive soluble guanylate cyclase stimulator. | ||||
| GC33898 | Plecanatide acetate | 1075732-84-1 | >99.00% | |
Plecanatide acetate, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. | ||||
| GC34045 | (4-Acetamidocyclohexyl) nitrate (BM121307) | 137213-91-3 | >98% | |
(4-Acetamidocyclohexyl) nitrate (BM121307) (BM121307) is a guanylate cyclase activator. | ||||
| GC36801 | Olinciguat | 1628732-62-6 | >98.00% | |
Olinciguat (IW-1701) is an oral guanylate cyclase (sGC) stimulator with concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole cell assay. | ||||
| GC39603 | Methylene blue trihydrate | 7220-79-3 | >99.00% | |
Methylene blue trihydrate (C. | ||||
| GC61604 | Guanylin(human) TFA | - | >97.00% | |
Guanylin(human) TFA, a 15-amino acid peptide, is an endogenous intestinal guanylate cyclase activator. | ||||
| GC62616 | MGV354 | - | >98% | |
MGV354 is a soluble guanylate cyclase (sGC) activator with EC50s of <0.5 nM, and 5 nM in CHO and GTM-3 E cells, respectively. | ||||
| GC63294 | MM 419447 | 1092457-78-7 | >99.00% | |
MM 419447, a linaclotide metabolite, is a guanylate cyclase-C agonist. | ||||
| GC64490 | (Rac)-MGV354 | 1852495-86-3 | >99.00% | |
(Rac)-MGV354 is the racemate of MGV354. | ||||
| GC65051 | BAY 60-2770 | 1027642-43-8 | >98% | |
BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. | ||||
| GC65182 | Zagociguat | 2201048-82-8 | >99.00% | |
Zagociguat is the stimulator of soluble guanylate cyclase. | ||||
| GC65192 | Runcaciguat | 1402936-61-1 | >99.00% | |
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists. | ||||
